Distribution of intestinal metaplasia as a predictor of gastric cancer development

Follow-up of premalignant lesions in patients at risk for progression to gastric cancer

(2013) C. den Hoed et al.   ENDOSCOPY

Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen andHelicobacter pyloriantibody titer

(2013) Takeichi Yoshida et al.   INTERNATIONAL JOURNAL OF CANCER

Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration

(2011) Kosuke Sakitani et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis

(2010) Lisette G. Capelle et al.   GASTROINTESTINAL ENDOSCOPY

Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn?

(2009) A C de Vries et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Early Helicobacter pylori Eradication Decreases Risk of Gastric Cancer in Patients With Peptic Ulcer Disease

(2009) Chun–Ying Wu et al.   GASTROENTEROLOGY

The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice

(2009) Annemarie C. de Vries et al.   GASTROINTESTINAL ENDOSCOPY

Eradication ofHelicobacter pyloriprevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels

(2009) Kimihiko Yanaoka et al.   INTERNATIONAL JOURNAL OF CANCER

Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the Netherlands

(2008) Annemarie C. de Vries et al.   GASTROENTEROLOGY

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

(2008) Kazutoshi Fukase et al.   LANCET